CAS: 452105-23-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 1H-Pyrrole-3-carboxaMide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-N-[(2S)-2-hydroxy-3-(4-Morpholinyl)propyl]-2,4-diMethyl- REF: IN-DA00DLOCCAS: 452105-23-6 | 98% | A consultar | Mar 07 Ene 25 |
 | (Z)-SU14813 REF: TM-T85345CAS: 452105-23-6 | 98.18% | 181,00 €~1.823,00 € | Mar 07 Ene 25 |
 | SU14813 double bond Z REF: 3D-CTA10523CAS: 452105-23-6 | Min. 95% | - - - | Producto descatalogado |
![1H-Pyrrole-3-carboxaMide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-N-[(2S)-...](https://static.cymitquimica.com/products/IN/thumb/DA00DLOC.jpg)
1H-Pyrrole-3-carboxaMide, 5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-N-[(2S)-2-hydroxy-3-(4-Morpholinyl)propyl]-2,4-diMethyl-
CAS:452105-23-6
Fórmula:
C23H27FN4O4
Pureza:
98%
Forma y color:
Solid
Peso molecular:
442.4833
Ref: IN-DA00DLOC
| 1mg | 258,00 € | ||
| 5mg | 607,00 € | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
(Z)-SU14813
CAS:452105-23-6
(Z)-SU14813 is a tyrosine kinase inhibitor with anticardiogenic and antitumor activity.
Fórmula:
C23H27FN4O4
Pureza:
98.18%
Forma y color:
Liquid
Peso molecular:
442.48
Ref: TM-T85345
| 1mg | 181,00 € | ||
| 5mg | 447,00 € | ||
| 10mg | 641,00 € | ||
| 25mg | 1.000,00 € | ||
| 50mg | 1.379,00 € | ||
| 100mg | 1.823,00 € |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
SU14813 double bond Z
CAS:452105-23-6
SU14813 is a potent inhibitor of angiogenesis and tumor growth. It has been shown to …
Fórmula:
C23H27FN4O4
Pureza:
Min. 95%
Peso molecular:
442.48 g/mol
Ref: 3D-CTA10523
| 5mg | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información |
